Tectonic Therapeutic, Inc. (TECX)
(Delayed Data from NSDQ)
$22.09 USD
+0.21 (0.96%)
Updated Aug 13, 2025 04:00 PM ET
After-Market: $22.11 +0.02 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
TECX 22.09 +0.21(0.96%)
Will TECX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TECX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TECX
Wall Street Analysts See a 258.52% Upside in Tectonic Therapeutic, Inc. (TECX): Can the Stock Really Move This High?
TECX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TECX
Analysts’ Top Healthcare Picks: Stereotaxis (STXS), Tectonic Therapeutic (TECX)
Tectonic Therapeutic GAAP EPS of -$1.07
12 Health Care Stocks Moving In Thursday's After-Market Session
Tectonic Therapeutic (TECX) Receives New Buy Rating from Truist Securities | TECX Stock News
Truist Recommends Buy for Tectonic Therapeutic (TECX) with $64 Target | TECX Stock News